By The Registry Staff Seattle-based Bonum Therapeutics, a rising star in the biotechnology sector, is set to double its current footprint in August as it plans to relocate to a larger office space in Seattle's Eastlake neighborhood. The company, which specializes in the development of targeted protein drugs for cancer treatment, is moving to a […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Issaquah is spending the last $3.4 million of a $16.3 million one-time-funded...
ByThe RegistryOctober 17, 2026Bellevue-based Wallace Properties paid $6.6 million for the 22,658-square-foot Creekside Professional Center...
ByThe RegistryOctober 17, 2026DSV's 750,000-square-foot owner-occupied hub in Hillsboro is the only one of the...
ByThe RegistryOctober 16, 2026Panattoni is finishing one of the largest speculative warehouses in Clark County...
ByThe RegistryOctober 16, 2026